064550 — BioneerCorp Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapFalling Star

Annual income statement for BioneerCorp, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	36,292	206,987	223,744	218,394	263,237
Cost of Revenue
Gross Profit	19,153	162,586	174,197	166,648	203,008
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	45,700	103,678	176,635	206,812	262,410
Operating Profit	-9,408	103,310	47,109	11,582	827
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-6,373	55,650	43,278	13,904	-67
Provision for Income Taxes
Net Income After Taxes	-7,420	59,188	29,199	15,122	-6,919
Minority Interest
Net Income Before Extraordinary Items
Net Income	-7,827	57,899	27,160	12,077	-10,587
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-7,827	59,111	27,160	12,077	-10,587
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-335	2,456	1,050	466	-411
Dividends per Share